Stryker Sustainability Solutions Cardiovascular Reprocessed ViewFlex Xtra ICE Catheter, REF D087031, OM St. Jude Medical, Size 9F (3.2mm), Length 90 cm, Sterile EO, Rx Only, Quantity 1, UDI: 07613327376067 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Cardiovascular Reprocessed ViewFlex Xtra ICE Catheter, REF D087031, OM St. Jude Medical, Size 9F (3.2mm), Length 90 cm, Sterile EO, Rx Only, Quantity 1, UDI: 07613327376067
Brand
Stryker Sustainability Solutions
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
2197475 2235448 2235454 2243623 2261903 2264435 2264468 2264478 2264484 2039314 2079692 2120924 2121216 2264953 2264955 2264983 2272787 2275104 2073119 2080853 2081724 2081992 2081993 2082097 2611753 2652454 2663966 2663971 2663956 2663959 2663973 2663997 2663999 2664000 2664027 2664028 2664038 2664039 2664041 2664042 2664054 2649640 2649643 2652050 2652100 2652106 2652108 2652123 2652127 2652128 2652130 2652131 2652175 2663895 2663904 2663905 2663907 2663909 2663929 2652008 2652010 2652011 2652080 2652084 2652085 2652090 2652097 2656413 2656414 2656415 2656421 2656442 2656443 2656444 2656448 2656449 2656450 2656458 2656462 2656463 2656474 2656475 2656479 2656485 2656488 2449500 2449504 2449584 2456071 2456077 2456078 2456593 2456604 2456605 2456607 2456609 2456610 2456620 2447265 2459137 2459155
Stryker Sustainability Solutions is recalling Cardiovascular Reprocessed ViewFlex Xtra ICE Catheter, REF D087031, OM St. Jude Medical, Size 9F (3. due to A subset of temporary intracardiac ultrasound catheters are labeled with the incorrect expiration date. They are mislabeled as having a shelf life of . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
A subset of temporary intracardiac ultrasound catheters are labeled with the incorrect expiration date. They are mislabeled as having a shelf life of two years, while the actual shelf life is one year. The earliest affected product will expire in May 2020. Use of mislabeled devices may lead to hazards sterility breach, component breakdown or delay in treatment.
Recommended Action
Per FDA guidance
The firm will execute the recall in four phases: 1) Provide the Urgent Medical Device Recall Customer Notification Letter and Recall Business Reply Form to sales representatives via UPS on 3/27/2020 to notify affected customers; 2) Send the Urgent Medical Device Recall Customer Notification Letter and Recall Business Reply Form directly to affected customers; 3) Follow up phone calls and/or emails to nonrespondent customers as needed; 4) Additional follow up attempts to non-respondent customers as needed. The Urgent Medical Device Recall Customer Notification Letter and Recall Business Reply Form, dated March 2, 2020 instructs customers the following: The following Customer Actions are communicated in the Urgent Medical Device Recall Customer Notification Letter: Affected products may continue to be used prior to the one-year shelf life expiration. All products used prior to May 2020 are within the validated shelf life. 1. Please check your inventory for the affected devices. Affected devices may be identified through Serial Number (see Attachments 1 and 2). 2. Please complete the Urgent Medical Device Recall Business Reply Form (page 5) and indicate if any of the affected product remains in your inventory. Please return this completed form through one of the following methods: a. Email: SSSPFA@stryker.com b. To your Stryker Sustainability Solutions Sales Representative c. Fax: 480-763-5345 All faxes sent to 480-763-5345 will redirect to the SSSPFA@stryker.com email inbox. This email inbox will be monitored and customer responses will be documented to determine which customers have responded to the recall notification This form must be completed and returned to Stryker even if no affected product is found. 3. If any of the affected devices have been forwarded to additional facilities, please contact these facilities and communicate this recall to them. 4. Maintain awareness of this communication internally until all required ac
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AZ, CA, FL, GA, ID, IL, IN, KS, MA, MO, PA, TN, TX, VA, WA, WV
Page updated: Jan 10, 2026